Tuberculosis kills approximately 1.25 million people every year, making it one of the deadliest infectious diseases on the planet. Without treatment, about half of people with active TB will die from it. With proper treatment, the vast majority survive, but millions of cases go undiagnosed or untreated each year, keeping the death toll stubbornly high.
The Numbers Behind TB Deaths
In the most recent global data, an estimated 10.8 million people developed new TB infections in a single year, and 1.25 million of them died. That puts TB ahead of HIV and malaria as a cause of death from a single infectious agent. The global death rate sits at about 13 per 100,000 people among those without HIV, and 2.0 per 100,000 among people living with HIV.
Children bear a disproportionate share of the burden. An estimated 174,000 children under 15 died from TB in 2024. The youngest are hit hardest: roughly 122,000 of those deaths were in children under five, whose immune systems are less equipped to contain the infection. Among adults, men account for about half of all TB deaths, while women account for about a third. The remainder are children and young adolescents.
Untreated TB Is a Coin Flip
The single most important number for understanding how deadly TB can be: without any treatment, the death rate for active tuberculosis is around 50%. That figure comes directly from the WHO, and it explains why TB was so feared before antibiotics existed. It also explains why gaps in diagnosis and treatment today translate so quickly into rising death counts.
Not everyone who inhales the TB bacteria develops active disease, though. Most people’s immune systems wall off the bacteria into a dormant state called latent TB infection. You feel fine, you can’t spread it, and you may never get sick. But without preventive treatment, 5% to 10% of people with latent TB will eventually develop active disease at some point in their lives. The risk jumps sharply if your immune system is compromised by HIV, malnutrition, diabetes, or other conditions.
How TB Actually Kills
TB primarily attacks the lungs, and that’s where it does its most lethal damage. The bacteria destroy lung tissue over weeks and months, forming cavities and triggering intense inflammation. As the disease progresses, the lungs lose their ability to exchange oxygen effectively. In severe cases, this leads to respiratory failure, where blood oxygen drops too low to sustain organ function.
Death from TB isn’t always a simple matter of lung destruction, though. Advanced disease can trigger a cascade of organ failures. Kidney dysfunction is common in hospitalized TB patients with breathing failure and significantly raises the risk of death. The infection can also spread beyond the lungs to the brain, spine, or bloodstream, each scenario carrying its own serious risks. When TB combines with other infections or chronic conditions, the body’s organs can fail one after another, and it’s often this multi-organ deterioration, rather than lung damage alone, that proves fatal.
HIV Makes TB Far More Dangerous
HIV and TB form what public health experts call a “deadly duo.” HIV cripples the very immune cells that keep TB bacteria in check, so people living with HIV are far more likely to develop active TB and far more likely to die from it. In 2023, an estimated 161,000 people with HIV died from tuberculosis. Among HIV-positive people who die in hospitals, autopsy studies have found TB is the cause of death in roughly 39% of cases, and nearly half of those TB cases were never diagnosed while the person was alive.
Drug-Resistant Strains Raise the Stakes
Standard TB is treatable with a combination of antibiotics taken over several months. But strains that resist those first-line drugs pose a much greater threat. Multi-drug resistant TB (MDR-TB) doesn’t respond to the two most powerful standard antibiotics, requiring longer, more toxic, and more expensive treatment regimens. Extensively drug-resistant TB (XDR-TB) resists even the backup drugs, leaving very few treatment options.
MDR-TB carries a global death rate of about 1.28 per 100,000 people, while XDR-TB’s rate is lower in absolute terms (0.01 per 100,000) simply because fewer people have it. Both forms have shown slowly increasing mortality trends over recent decades. For individual patients, drug-resistant TB means treatment that can stretch to 18 months or longer, with medications that carry significant side effects, and a meaningfully lower chance of cure compared to standard TB.
Millions Die Without Ever Being Diagnosed
One of the most alarming aspects of TB mortality is how many people die without anyone knowing they had TB. Studies using autopsy data have consistently found that a large fraction of TB deaths were never diagnosed. At one hospital in Zambia, 62% of inpatient deaths were caused by TB, and a quarter of those patients hadn’t been diagnosed at admission. A study using advanced DNA testing on cadavers found that 14% of non-trauma deaths were caused by TB, and 80% of those cases had been missed before death.
These aren’t just statistical curiosities. Every undiagnosed person with active TB can spread the bacteria to 10 to 15 others over the course of a year. Missed diagnoses don’t just kill the individual patient; they fuel ongoing transmission in communities.
Where TB Kills the Most
TB deaths are concentrated heavily in low- and middle-income countries. India leads the world with an estimated 305,000 TB deaths per year, followed by Indonesia with 126,000 and the Democratic Republic of the Congo with 66,000. These three countries alone account for roughly 40% of all global TB deaths. The burden tracks closely with poverty, overcrowded housing, limited healthcare access, and high rates of HIV.
In wealthy countries with strong healthcare systems, TB death rates are comparatively low. But the disease hasn’t disappeared from these settings. Outbreaks still occur in prisons, homeless shelters, and immigrant communities, and drug-resistant strains can emerge anywhere antibiotics are used improperly.
Treatment Transforms the Odds
The gap between treated and untreated TB is enormous. Untreated, your odds of dying are roughly one in two. With a standard course of antibiotics, typically four drugs taken over six months, the vast majority of patients with drug-susceptible TB are cured. The treatment is demanding: it requires consistent daily medication for months, and stopping early is one of the main drivers of drug resistance. But for those who complete the full course, TB shifts from a likely death sentence to a curable infection.
For latent TB, preventive treatment can reduce the risk of ever developing active disease by 60% to 90%, depending on the regimen. Shorter courses lasting three to four months have made preventive treatment more practical in recent years. If you’ve been exposed to someone with TB or have tested positive for latent infection, treatment at this stage is the most effective way to ensure the bacteria never become dangerous.